_____________________
Team vector presentation
Schema @nathalie Mignet
The team main interest is on the design of nanomedicine, i.e. nanoparticles for targeted drug delivery or as specific imaging markers. The drug delivery axis covers formulations dedicated to local administration (mucoadhesive liquid/gel forms) and systemic (liposomes, multiple emulsions). The imaging axis aims to follow vectors by optical imaging in small animals, or to design specific probes such as microbubbles for ultrasound or nanoparticle MRI contrast agents. The strength of the team lies in the interdisciplinarity of the personnel which brings together organic chemistry, physicochemistry, pharmacotechnics, and biology (animal experimentation, imaging, tumor models), and their membership of Inserm, CNRS, university and hospital. The team has all the assets in hand to carry out cross-cutting research in the fields of nanomedicine.
Keywords: Functionalized Nanovectors, Pharmacotechnology, Targeting, Particle Imaging Agents, Nanomedicine, Physical Chemistry of Drugs
_____________________
À lire aussi
UTCBS takes part in the Faculty of Pharmacy Scientific Day
UTCBS takes part in the Faculty of Pharmacy Scientific Day
Job offer : Two-year Postdoctoral Position. Project: FunkNano4Cancer – Functionalisation of nanoparticles for improved diagnostics and anti-cancer efficacy
Job offer : Two-year Postdoctoral Position. Project: FunkNano4Cancer – Functionalisation of nanoparticles for improved diagnostics and anti-cancer efficacy.
1st meeting on Lipid Nanoparticles for delivery
Nathalie Mignet and her team, in association with the Société Française de Nanomédecine, are organizing the 1st meeting on Lipid Nanoparticles for RNA delivery on Thursday April 3, 2025 at the Faculté de Pharmacie in Paris.
Nathalie Mignet, at the “advances in nanomedicine” international conference
The international conference “advances in nanomedicine” organized by the editorial office of the journal Precision Nanomedecine and the Kalinga Institute in Bhubaneswar, Odisha, India, brought together the leading names in nanomedicine, Lou Balogh, editor-in-chief of...